Trendlines(42T.SI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

42T.SI Trendlines

Closed 11-26 17:16:00 SGT Delay

0.0520

+0.0010

+1.96%

High0.0550	Low0.0520	Vol50.40K
Open0.0550	D1 Closing0.0510	Amplitude5.88%
Mkt Cap56.79M	Tradable Cap22.43M	Total Shares1.09B
T/O2.62K	T/O Rate0.01%	Tradable Shares431.41M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"42T.SI","market":"SI","secType":"STK","nameCN":"Trendlines","latestPrice":0.052,"timestamp":1732612560000,"preClose":0.051,"halted":0,"volume":50400,"delay":15,"nameEN":"Trendlines","floatShares":431408955,"shares":1092054062,"eps":-0.055143695852199325,"marketStatus":"Closed","change":0.001,"latestTime":"11-26 17:16:00 SGT Delay","open":0.055,"high":0.055,"low":0.052,"amount":2622,"amplitude":0.058824,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.055143695852199325,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1732667400000},"marketStatusCode":5,"adr":0,"exchange":"SGX","adjPreClose":0.051,"openAndCloseTimeList":[[1732581000000,1732593600000],[1732597200000,1732612560000]],"volumeRatio":0.94951,"lotSize":100,"tradeCurrency":"SGD"},"requestUrl":"/m/hq/s/42T.SI","defaultTab":"news","newsList":[{"id":"2484113177","title":"The Trendlines to Merge Wholly Owned Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2484113177","media":"MT Newswires","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484113177?lang=en_us&edition=fundamental","pubTime":"2024-11-20 11:41","pubTimestamp":1732074105,"startTime":"0","endTime":"0","summary":"The Trendlines  board decided to merge wholly owned subsidiary, Trendlines Investments Israel in an absorption type merger, according to a filing with the Singapore Exchange on Tuesday.The merger is part of company's strategy for operational, administrative, financial and tax reasons.Prior to the merger, the absorbed company will transfer its franchise granted by the Israel Innovation Authority to the company.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["42T.SI","BK6516","BK6052"],"gpt_icon":0},{"id":"2481016534","title":"Trendlines Group Completes First Tranche of Share Subscription Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2481016534","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481016534?lang=en_us&edition=fundamental","pubTime":"2024-11-08 07:12","pubTimestamp":1731021132,"startTime":"0","endTime":"0","summary":"Trendlines Group  completed the first tranche of its proposed subscription, issuing new shares at SG$0.06 each, according to a Thursday filing on the Singapore Exchange.The subscription increased the company's total shares to 1.09 billion from 1.02 billion.Notably, certain subscribers, including Rich Silverstein and Meyer Jeger, were excluded from this tranche. The shares will rank equally with existing shares, excluding specific restrictions for US investors.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["42T.SI","BK6516","BK6052"],"gpt_icon":0},{"id":"2481902628","title":"Limaca's Precision-GI™ Granted CMS Transitional Pass-Through (TPT) Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2481902628","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481902628?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:00","pubTimestamp":1730984400,"startTime":"0","endTime":"0","summary":"Precision-GI FDA Designated Breakthrough product and FDA cleared semi-automated motorized endoscopic biopsy device entering U.S. market. YOKNEAM, Israel, Nov. 7, 2024 /PRNewswire/ -- The Centers for Medicare & Medicaid Services  has granted transitional pass-through  payment for Limaca Medical Ltd. 's Precision-GI motorized endoscopic biopsy device. Limaca's endoscopic device is designed to obtain improved biopsy results for patients with suspected gastrointestinal cancers such as pancreatic, liver, and other GI-related and adjacent organs cancers and illnesses. The Precision-GI TPT grant is for up to three years beginningJanuary 1, 2025, thus supporting patient access to Limaca's new and innovative technology; previously, Precision-GI was granted the FDA's Breakthrough Device Designation in 2022 and received clearance by the U.S. Food and Drug Administration  inAugust 2023.Limaca's Precision-GI performed its first U.S.-based cases in September 2024 and is now commencing U.S. market en","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/WN5J50u_wJ0hC0TAl9bSHw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/2083d11d0f214568d3e3d481af0f5046","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/WN5J50u_wJ0hC0TAl9bSHw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/2083d11d0f214568d3e3d481af0f5046"],"rights":{"source":"yahoofinance_sg","url":"https://finance.yahoo.com/news/limacas-precision-gi-granted-cms-130000227.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/limacas-precision-gi-granted-cms-130000227.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_sg","symbols":["BK6052","LU1894683348.USD","BK4208","LU1894683264.USD","LU2346227817.USD","BK6516","LU2637428348.USD","BK4135","TRNLY","42T.SI","BK4585","CMS","BK4588"],"gpt_icon":0},{"id":"2480371574","title":"the Trendlines Group Ltd. Trendlines Monthly Update - October 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2480371574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480371574?lang=en_us&edition=fundamental","pubTime":"2024-11-04 17:23","pubTimestamp":1730712193,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nTUE9PSZTD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["42T.SI","BK6516","BK6052"],"gpt_icon":0},{"id":"2478104854","title":"Vensica Medical Secures $11M in Funding to Support Phase 2 Trials for Overactive Bladder Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2478104854","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478104854?lang=en_us&edition=fundamental","pubTime":"2024-10-28 20:00","pubTimestamp":1730116818,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241028:nTUABZZB68:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["42T.SI","BK6516","BK6052"],"gpt_icon":0},{"id":"2478104838","title":"Elastimed Welcomes DR. Amir Belson as a Member of the Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2478104838","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478104838?lang=en_us&edition=fundamental","pubTime":"2024-10-28 20:00","pubTimestamp":1730116804,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241028:nTUAC6ZH3H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK6052","42T.SI","BK6516"],"gpt_icon":0},{"id":"2478104899","title":"Press Release: ElastiMed Welcomes Dr. Amir Belson as a Member of the Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2478104899","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478104899?lang=en_us&edition=fundamental","pubTime":"2024-10-28 20:00","pubTimestamp":1730116800,"startTime":"0","endTime":"0","summary":"YOKNEAM, Israel, Oct. 28, 2024 /PRNewswire/ -- ElastiMed Ltd. a leading innovator in wearable medical devices, is proud to announce the appointment of Dr. Amir Belson as a member of its Board of Directors.\"I am honored to join ElastiMed as a member of the Board,\" said Dr. Belson. \"ElastiMed is by far the most innovative company in the compression therapy arena. Their wearable medical devices will bring relief to tens of millions of lymphatic and venous disease sufferers around the world and empower them to lead the life they wish rather than being limited by their conditions. I am excited to work with the talented team to drive additional innovation and create impactful solutions for patients and healthcare providers.\". For more information about Elastimed and its innovative products, please visit www.elastimed.com","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6052","42T.SI","BK6516","TRNLY","BK4135"],"gpt_icon":0},{"id":"2478104212","title":"Vensica Medical Secures $11M in Funding to Support Phase 2 Trials for Overactive Bladder Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2478104212","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478104212?lang=en_us&edition=fundamental","pubTime":"2024-10-28 20:00","pubTimestamp":1730116800,"startTime":"0","endTime":"0","summary":"Backed byIBF, Merz, and Laborie, Vensica to Advance Needle-Free Delivery of Botulinum Toxin A  for Minimally Invasive Treatment. BROOKLYN, N.Y., Oct. 28, 2024 /PRNewswire/ -- Vensica Medical ,a pioneering urology therapeutics company, today announced the successful closing of an $11 million funding round. The investment will fund the company's upcoming Phase 2 clinical trials across the United States and Europe for its revolutionary treatment of overactive bladder  using botulinum toxin A  delivered through a proprietary, needle-free device.The investment round was led by Israel Biotech Fund , alongside key strategic partners, Merz, a global player in neurotoxins, and Laborie, a prominent urology medical device company. This funding will enable Vensica to continue its mission of providing a minimally invasive, simple, and effective solution for people with overactive bladder .Vensica's unique technology leverages a needle-free drug delivery system, that administers Xeomin directly to t","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/p3vFo7StF7mLpljZfFdc4A--~B/aD0yNjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/8302bfbcb6cd75c05eda4c989475cf54","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/p3vFo7StF7mLpljZfFdc4A--~B/aD0yNjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/8302bfbcb6cd75c05eda4c989475cf54"],"rights":{"source":"yahoofinance_sg","url":"https://finance.yahoo.com/news/vensica-medical-secures-11m-funding-120000535.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vensica-medical-secures-11m-funding-120000535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_sg","symbols":["TRNLY","BK4135","BK6516","BK6052","42T.SI"],"gpt_icon":0},{"id":"2474731477","title":"Trendlines Group Revises Terms for Share Subscription Deal After Subscriber Withdrawals","url":"https://stock-news.laohu8.com/highlight/detail?id=2474731477","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474731477?lang=en_us&edition=fundamental","pubTime":"2024-10-10 09:55","pubTimestamp":1728525348,"startTime":"0","endTime":"0","summary":"Trendlines  disclosed changes to its proposed subscription of up to 76.6 million new ordinary shares at a subscription price of SG$0.06 each, according to a Wednesday filing on the Singapore Exchange.Two subscribers, Rich Silverstein and Meyer Jeger, have opted not to proceed with their payments, while RRAOS Enterprises has not communicated a payment timeline. FEA Innovations has requested additional time for payment.The company plans to complete the subscription in two tranches.The first tranche will involve all other subscribers except the three mentioned. The second tranche will only include FEA Innovations and, if applicable, RRAOS Enterprises, contingent on their respective payments.The first tranche will issue 67.2 million shares, while the aggregate number of shares to be subscribed for in the second tranche will depend on payments from FEA Innovations and RRAOS Enterprises.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6516","BK6052","42T.SI"],"gpt_icon":1},{"id":"2474433782","title":"the Trendlines Group Ltd. Update Announcement Proposed Subscription","url":"https://stock-news.laohu8.com/highlight/detail?id=2474433782","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474433782?lang=en_us&edition=fundamental","pubTime":"2024-10-09 19:02","pubTimestamp":1728471730,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241009:nTUE5QMD61:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK6052","42T.SI","BK6516"],"gpt_icon":0},{"id":"2472834284","title":"Singapore Shares End Marginally Lower; Nio Drops 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472834284","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472834284?lang=en_us&edition=fundamental","pubTime":"2024-10-01 17:57","pubTimestamp":1727776645,"startTime":"0","endTime":"0","summary":"Singapore's stock market closed marginally lower on Tuesday despite US Federal Reserve chair Jerom Powell hinting at further interest rate cuts.The Straits Times Index (STI), a key benchmark for the S","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BS6.SI","BK6052","BK6117","S59.SI","O39.SI","BK6079","BK6512","NIO","AOF.SI","STI.SI","BK6506","BFK.SI","42T.SI","C6L.SI","BK6516"],"gpt_icon":1},{"id":"2472344784","title":"the Trendlines Group Ltd. Trendlines Monthly Update - September 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2472344784","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472344784?lang=en_us&edition=fundamental","pubTime":"2024-10-01 17:43","pubTimestamp":1727775824,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241001:nTUE5D2FDZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK6052","42T.SI","BK6516"],"gpt_icon":0},{"id":"2472080397","title":"The Trendlines Group Maintains Operations in Israel Despite Security Concerns; Shares Surge 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472080397","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472080397?lang=en_us&edition=fundamental","pubTime":"2024-10-01 12:08","pubTimestamp":1727755716,"startTime":"0","endTime":"0","summary":"The Trendlines Group (SGX:42T) says that it will continue its business operations despite security situation in Israel, a filing with the Singapore Exchange said on Monday.The company is closely follo","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["42T.SI","BK6516","BK6052"],"gpt_icon":0},{"id":"2471803577","title":"the Trendlines Group Ltd. Trendlines Update on Security Situation","url":"https://stock-news.laohu8.com/highlight/detail?id=2471803577","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471803577?lang=en_us&edition=fundamental","pubTime":"2024-09-30 19:04","pubTimestamp":1727694263,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240930:nTUE6KRBJG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK6516","BK6052","42T.SI"],"gpt_icon":0},{"id":"2464290839","title":"the Trendlines Group Ltd. Trendlines Monthly Update - August 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2464290839","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464290839?lang=en_us&edition=fundamental","pubTime":"2024-09-02 20:35","pubTimestamp":1725280553,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240902:nTUE79Y4GR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["42T.SI","BK6052","BK6516"],"gpt_icon":0},{"id":"2462991431","title":"Singapore Shares Marginally Lower; KIT Falls 2%; Lum Chang Rises 1.7%; Trendlines Jumps 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462991431","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2462991431?lang=en_us&edition=fundamental","pubTime":"2024-08-28 17:56","pubTimestamp":1724838992,"startTime":"0","endTime":"0","summary":"Singapore's stock market closed marginally higher on Wednesday, despite gains in the global markets.The Straits Times Index (STI), a key benchmark for the Singapore Exchange, ranged between 3,373.19 a","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJZ.SI","BK6045","BK6052","BK6505","STI.SI","BK6516","A7RU.SI","42T.SI","BK6520","L19.SI","BK6022"],"gpt_icon":1},{"id":"2462171190","title":"Trendlines Secures $1.5 Million Investment from Controlling Shareholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2462171190","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2462171190?lang=en_us&edition=fundamental","pubTime":"2024-08-28 10:19","pubTimestamp":1724811561,"startTime":"0","endTime":"0","summary":"Trendlines  has approved investments totaling $1.5 million from controlling shareholder Librae Holdings and $992,000 from Trendlines itself in its portfolio companies, according to a Tuesday filing with the Singapore Exchange.Librae will invest in nine companies through various agreements, including share purchase agreements, simple agreements for future equity, and convertible loan agreements.Key investments include $400,000 in Vessi Medical and $300,000 in ProArc from Librae, and $200,000 in Limaca Medical and Arcuro Medical from Trendlines.The transactions are on normal commercial terms and are not expected to significantly impact Trendlines' financials or net tangible assets for the year ending Dec. 31, the filing said.Trendlines' shares were up almost 2% in recent Wednesday trade.Price : S$0.06, Change: S$+0.001, Percent Change: +1.85%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["42T.SI","BK6516","BK6052"],"gpt_icon":0},{"id":"2457331544","title":"The Trendlines Net Attributable Profit Plummets 64% in H1","url":"https://stock-news.laohu8.com/highlight/detail?id=2457331544","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2457331544?lang=en_us&edition=fundamental","pubTime":"2024-08-08 12:16","pubTimestamp":1723090606,"startTime":"0","endTime":"0","summary":"The Trendlines'  net attributable profit to equity holders in H1 plummeted 64% year over year to $1.6 million from $4.5 million, according to a filing with the Singapore Exchange on Wednesday.EPS came in at $0.0017 during the period, compared with $0.0052 in the comparable period.Total income was down 49% year-over-year to $6.4 million from $12.4 million, due to a decrease in income from contracted R&D services and portfolio companies.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["42T.SI","BK6052","BK6516"],"gpt_icon":0},{"id":"2457724310","title":"Arcuro Medical Exceeds 4,000 Case Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2457724310","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2457724310?lang=en_us&edition=fundamental","pubTime":"2024-08-05 20:00","pubTimestamp":1722859200,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS and MISGAV, Israel, Aug. 5, 2024 /PRNewswire/ -- Arcuro Medical Ltd.,  today announced a key milestone of exceeding 4,000 surgical cases worldwide, and 1,000 cases in the U.S., with its SuperBall Meniscal Repair System.Jamal Rushdy, Arcuro's CEO, commented, \"We are excited to have reached this important milestone of global cases, and most significantly surpassing 1,000 cases here in the U.S. We look forward to continuing growth with our expanded U.S. sales organization.\". Philip Davidson, MD, Arcuro's Medical Director added, \"The SuperBall Meniscal Repair System provides an important all-suture, knotless tool for surgeons to effectively address a wide range of tears. Its unique tensioning mechanism is similar to the inside-out gold standard technique and has been shown to provide superior strength and reduced deployment failure and other complications associated with other meniscus repair devices.[1]\". Recently, Arcuro made two key hires in the United States to focus on com","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/TZJgTbGVyUL0VlHOsuvcFg--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/9c70715de78c7126c4e2bf1f3d66d915","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/TZJgTbGVyUL0VlHOsuvcFg--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/9c70715de78c7126c4e2bf1f3d66d915"],"rights":{"source":"yahoofinance_sg","url":"https://finance.yahoo.com/news/arcuro-medical-exceeds-4-000-120000125.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arcuro-medical-exceeds-4-000-120000125.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_sg","symbols":["BK6052","BK4135","42T.SI","TRNLY","BK6516"],"gpt_icon":0},{"id":"2457193937","title":"Trendlines Group Updates on Proposed Share Subscription Deal, Portfolio Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2457193937","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2457193937?lang=en_us&edition=fundamental","pubTime":"2024-08-05 14:58","pubTimestamp":1722841096,"startTime":"0","endTime":"0","summary":"Trendlines Group  revealed the proposed subscription of an aggregate of up to 76,576,577 shares in the company's capital at a price of SG$0.06 per share, according to a filing with the Singapore Exchange on Friday.Meanwhile, the company's portfolio company, Dasyo appointed Domenic Serafino as the executive chair of its board of directors.The company will release its financial statements for H1 on or around Aug. 7.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6516","42T.SI","BK6052"],"gpt_icon":1}],"profile":{"websiteUrl":"https://www.trendlines.com/","stockEarnings":[{"period":"1week","weight":-0.0556},{"period":"1month","weight":-0.0556},{"period":"3month","weight":-0.0556},{"period":"6month","weight":-0.2388},{"period":"1year","weight":-0.427},{"period":"ytd","weight":-0.4396}],"compareEarnings":[{"period":"1week","weight":0.0061},{"period":"1month","weight":0.0465},{"period":"3month","weight":0.1081},{"period":"6month","weight":0.157},{"period":"1year","weight":0.2657},{"period":"ytd","weight":0.2129}],"compareStock":{"symbol":"ES3.SI","name":"STI ETF"},"description":"Trendlines Group Ltd is an Israel-based life sciences innovation commercialization company, which invents, discovers, invests in, partners and incubates innovation based medical and agricultural technologies. It invests principally through four business units: two Israeli government-franchised incubators, Trendlines Medical and Trendlines Agtech, a Singapore incubator, Trendlines Medical Singapore, and an in-house innovation center, Trendlines Labs. The Group’ s portfolio include more than 50 companies engaged with medical and agricultural technologies and products. The Group is involved in all aspects of its portfolio companies from technology development to business building. The Group in partnerships with entrepreneurs, investors, strategic players, inventors, and governments aims to improve the human condition.","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":-0.046699},{"month":2,"riseRate":0.222222,"avgChangeRate":-0.000348},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.02255},{"month":4,"riseRate":0.555556,"avgChangeRate":0.040739},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.021573},{"month":6,"riseRate":0.222222,"avgChangeRate":-0.018164},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.017344},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.040007},{"month":9,"riseRate":0.555556,"avgChangeRate":0.0016},{"month":10,"riseRate":0.444444,"avgChangeRate":0.001182},{"month":11,"riseRate":0.444444,"avgChangeRate":-0.010587},{"month":12,"riseRate":0.555556,"avgChangeRate":0.003005}],"exchange":"SGX","name":"Trendlines","nameEN":"Trendlines"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Trendlines(42T.SI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Trendlines(42T.SI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Trendlines,42T.SI,Trendlines股票,Trendlines股票老虎,Trendlines股票老虎国际,Trendlines行情,Trendlines股票行情,Trendlines股价,Trendlines股市,Trendlines股票价格,Trendlines股票交易,Trendlines股票购买,Trendlines股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Trendlines(42T.SI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Trendlines(42T.SI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction